These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1054 related items for PubMed ID: 8596547

  • 21. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
    Yosry A, Esmat G, El-Serafy M, Omar A, Doss W, Said M, Abdel-Bary A, Hosny A, Marawan I, El-Malt O, Kamel RR, Hatata Y, Ghali A, Sabri H, Kamel S, El-Gbaly H, Tanaka K.
    Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
    [Abstract] [Full Text] [Related]

  • 22. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
    Takada Y, Haga H, Ito T, Nabeshima M, Ogawa K, Kasahara M, Oike F, Ueda M, Egawa H, Tanaka K.
    Transplantation; 2006 Feb 15; 81(3):350-4. PubMed ID: 16477219
    [Abstract] [Full Text] [Related]

  • 23. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P, Loreno M, Russo FP, Germani G, Galligioni A, Senzolo M, Cillo U, Zanus G, Fagiuoli S, Rugge M.
    Liver Transpl; 2009 Jun 15; 15(6):619-28. PubMed ID: 19479805
    [Abstract] [Full Text] [Related]

  • 24. [Recurrence of hepatitis caused by hepatitis c virus in patients receiving a liver transplant].
    Crespo J, Casafont F, Carte B, Lozano JL, Fábrega E, Sánchez-Antolín G, Dueñas C, Pons Romero F.
    Med Clin (Barc); 1997 Jan 25; 108(3):98-102. PubMed ID: 9064439
    [Abstract] [Full Text] [Related]

  • 25. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation.
    Berenguer M, Prieto M, Rayón JM, Mora J, Pastor M, Ortiz V, Carrasco D, San Juan F, Burgueño MD, Mir J, Berenguer J.
    Hepatology; 2000 Oct 25; 32(4 Pt 1):852-8. PubMed ID: 11003634
    [Abstract] [Full Text] [Related]

  • 26. Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.
    Crespo J, Carte B, Lozano JL, Casafont F, Rivero M, de la Cruz F, Pons-Romero F.
    Am J Gastroenterol; 1997 Sep 25; 92(9):1458-62. PubMed ID: 9317062
    [Abstract] [Full Text] [Related]

  • 27. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
    Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Cammà C, De Carlis L, Minola E, Quaglia A, Zavaglia C, Vangeli M, Patch D, Dhillon A, Cillo U, Guido M, Fagiuoli S, Giacomoni A, Slim OA, Airoldi A, Boninsegna S, Davidson BR, Rolles K, Pinzello G.
    Liver Transpl; 2007 May 25; 13(5):733-40. PubMed ID: 17370330
    [Abstract] [Full Text] [Related]

  • 28. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus.
    Taner CB, Bulatao IG, Keaveny AP, Willingham DL, Pungpapong S, Perry DK, Rosser BG, Harnois DM, Aranda-Michel J, Nguyen JH.
    Liver Transpl; 2011 Jun 25; 17(6):641-9. PubMed ID: 21618684
    [Abstract] [Full Text] [Related]

  • 29. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
    Aguilera V, Berenguer M, Rubín A, San-Juan F, Rayón JM, Prieto M, Mir J.
    Liver Transpl; 2009 Jan 25; 15(1):79-87. PubMed ID: 19109849
    [Abstract] [Full Text] [Related]

  • 30. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
    Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, Paya CV, Charlton MR.
    Liver Transpl; 2002 Apr 25; 8(4):362-9. PubMed ID: 11965581
    [Abstract] [Full Text] [Related]

  • 31. Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis.
    Radecke K, Frühauf NR, Miller M, Ross B, Köditz R, Malagó M, Broelsch CE, Gerken G, Treichel U.
    Liver Int; 2005 Feb 25; 25(1):101-8. PubMed ID: 15698406
    [Abstract] [Full Text] [Related]

  • 32. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC, Yan LN, Li B, Wen TF, Zhao JC, Cheng NS, Liu C, Liu J, Wang XB, Li XD, Qin S, Zhao LS, Lei BJ, Zhang XH.
    Hepatobiliary Pancreat Dis Int; 2004 Feb 25; 3(1):26-32. PubMed ID: 14969833
    [Abstract] [Full Text] [Related]

  • 33. Long-term results and modeling to predict outcomes in recipients with HCV infection: results of the NIDDK liver transplantation database.
    Charlton M, Ruppert K, Belle SH, Bass N, Schafer D, Wiesner RH, Detre K, Wei Y, Everhart J.
    Liver Transpl; 2004 Sep 25; 10(9):1120-30. PubMed ID: 15350002
    [Abstract] [Full Text] [Related]

  • 34. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
    Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE.
    Liver Transpl; 2009 Dec 25; 15(12):1872-81. PubMed ID: 19938138
    [Abstract] [Full Text] [Related]

  • 35. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
    Manousou P, Samonakis D, Cholongitas E, Patch D, O'Beirne J, Dhillon AP, Rolles K, McCormick A, Hayes P, Burroughs AK.
    Liver Transpl; 2009 Dec 25; 15(12):1783-91. PubMed ID: 19938143
    [Abstract] [Full Text] [Related]

  • 36. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.
    Tao R, Ruppert K, Cruz RJ, Malik SM, Shaikh O, Ahmad J, DiMartini A, Humar A, Fontes PA, de Vera ME.
    Liver Transpl; 2010 Nov 25; 16(11):1288-95. PubMed ID: 21031544
    [Abstract] [Full Text] [Related]

  • 37. Allograft transmission of hepatitis C virus infection from infected donors in cardiac transplantation.
    File E, Mehra M, Nair S, Dumas-Hicks D, Perrillo R.
    Transplantation; 2003 Oct 15; 76(7):1096-100. PubMed ID: 14557759
    [Abstract] [Full Text] [Related]

  • 38. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J, Ciria R, Pleguezuelo M, de la Mata M, Muntané J, Naranjo A, Sánchez-Hidalgo J, Marchal T, Rufián S, López-Cillero P.
    Liver Transpl; 2009 Jan 15; 15(1):37-48. PubMed ID: 19109846
    [Abstract] [Full Text] [Related]

  • 39. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis.
    Benvegnù L, Pontisso P, Cavalletto D, Noventa F, Chemello L, Alberti A.
    Hepatology; 1997 Jan 15; 25(1):211-5. PubMed ID: 8985292
    [Abstract] [Full Text] [Related]

  • 40. Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation.
    Langrehr JM, Puhl G, Bahra M, Schmeding M, Spinelli A, Berg T, Schönemann C, Krenn V, Neuhaus P, Neumann UP.
    Liver Transpl; 2006 Apr 15; 12(4):644-51. PubMed ID: 16555324
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 53.